And how do you expect members of Parliament on the finance committee to determine whether we should give priority to people suffering from lung disease, or for research for lung disease? We just had the diabetes association and numerous other groups who have asked for research money.
How can you help us make that decision? Where's the cut-off? When is there enough money, and how do we reconcile the requests?